JESSICA WEST: Open Payments
NPI 1457808586 · ALPHARETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$889 in 42 payments from 18 companies in 2025. Trend: 2023 $1,581 · 2024 $1,346 · 2025 $889
Food & beverage: $889
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $115 |
| AstraZeneca Pharmaceuticals LP | 6 | $106 |
| Novo Nordisk Inc | 5 | $101 |
| PFIZER INC. | 4 | $99 |
| Amgen Inc. | 3 | $57 |
| Astellas Pharma US Inc | 2 | $54 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $45 |
| Lilly USA, LLC | 2 | $44 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $41 |
| Sumitomo Pharma America, Inc. | 2 | $38 |
Products named: QULIPTA, FARXIGA, JARDIANCE, NURTEC ODT, Rybelsus, Veozah, XIFAXAN, GEMTESA.
Industry payments across GA — which companies pay providers there.
